BioSpace News Archive

Aardvark Therapeutics, Inc., a clinical stage biopharmaceutical company, today reported positive clinical data from three Phase II trials for its lead program ARD-101, an oral small molecule bitter taste receptor (TAS2R) agonist.

CancerVAX, Inc. announced that its UCLA research team has made positive progress towards developing a treatment for Ewing sarcoma, a deadly form of kids cancer.

Generate:Biomedicines announced that Dr. Alexandra Snyder has been appointed to Executive Vice President, Research & Development, in addition to her current responsibilities as Chief Medical Officer, effective immediately.

Compliance and ethics professionals from around the globe will gather in Chicago October 2–5, 2023, for the 22nd Annual Compliance & Ethics Institute, the flagship conference of Society of Corporate Compliance and Ethics®.

Image rotations were reduced by up to 91% according to Frost & Sullivan’s study of two hospitals using Agfa’s AI.

Akoya Biosciences, Inc., The Spatial Biology Company®, announced that Company management will be participating in two upcoming investor conferences.

Galapagos NV announced that during its meeting of 12 June 2023, the Board of Directors co-opted Dr. Susanne Schaffert as non-executive independent Director.

Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced a focused oral presentation on zigakibart (BION-1301) will be presented on Friday, June 16, 2023 at the 60th ERA Congress being held virtually and live in Milan, Italy.

Spruce Biosciences, Inc. announced that a submitted abstract was accepted for the 105th Annual Meeting of the Endocrine Society taking place June 15-18, 2023, in Chicago.

Starton Therapeutics Inc., a clinical stage biotechnology company focused on transforming standard-of-care therapies with proprietary continuous delivery technology, provided updates on its Phase 1b STAR-LLD clinical trial of its investigational continuous delivery lenalidomide in multiple myeloma.